Archive
Every story, newest first.
Friday, October 30, 2026
Commodities
BMI, a unit of Fitch Solutions, warns that a strong to very strong El Nino lasting through early 2027 threatens copper and nickel production through flooding in South America, hydropower shortages in Africa and water constraints at Indonesian nickel smelters.
Commodities
Russia resumed granting departure permits to grain ships in the Sea of Azov on October 26 for the first time since July, with at least one vessel passing through the Kerch Strait into the Black Sea by October 29.
Commodities
Cosco Shipping Holdings reported third quarter net income up 81 percent to 17.2 billion yuan, about 2.6 billion dollars, its biggest jump in two years, as geopolitical rerouting tied up vessels for longer and container rates surged.
Commodities
Nearly 70 percent of the world's visible exchange copper stocks, 718,000 tonnes, now sit in COMEX warehouses in the United States, a GEM Mining Consulting study found, while combined London and Shanghai inventories stand 11 percent below their 2015 to 2024 average.
Commodities
LNG imports accounted for a record 31 percent of Colombia's monthly natural gas supply in July 2026, the EIA reported, as domestic production fell to an average of 673 million cubic feet a day in the first eight months of the year.
Commodities
Cheniere Energy exported a record 188 LNG cargoes totalling 684 trillion British thermal units in the third quarter, up 17 percent on a year earlier, and raised its full year adjusted earnings guidance to between 8.75 billion and 9.25 billion dollars.
Commodities
ANZ raised its year end Brent forecast by 10 dollars to 105 dollars a barrel on Friday, joining UBS at 110 dollars, while Goldman Sachs holds at 90 dollars with risks skewed to the upside.
Life Sciences
AstraZeneca reported third quarter revenue up 7 percent to $16.21 billion on October 30 and launched a restructuring programme meant to deliver about $1.5 billion in annualised benefits, at one time costs of up to $2.0 billion, to fund its pipeline.
Life Sciences
Aspen Neuroscience priced its initial public offering at $15 per share on October 29, raising $140.6 million gross, while Bambusa Therapeutics upsized its offering to 10,555,555 shares at $16 for gross proceeds of $168,888,880, with both stocks set to debut on Nasdaq on October 30.
Life Sciences
Alnylam reported third quarter total revenue up 17 percent to $1.458 billion on October 29, with Amvuttra sales up 65 percent to $1.130 billion, but said full year transthyretin revenue will likely land near the low end of its $4.2 billion to $4.5 billion range.